These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 21 through Nov. 27, 2024. Source: VerityData
Increases in Holdings
Sleep Number Stadium Capital Management raised its stake in the bed maker to 2,616,459 shares. Stadium Capital did so through the purchase of 160,198 Sleep Number shares from Nov. 5 through Nov. 18, 2024, at per share prices ranging from $12.04 to $15. On Nov. 25, Stadium issued a letter to Sleep Number's board requesting that the two collaborate to refresh the board and facilitate an independent CEO search following the retirement of former CEO Shelly Ibach.
After the latest purchases, Stadium Capital Management now owns 11.7% of Sleep Number's outstanding stock. Shares of Sleep Number have lost roughly 1.8% during the year.
Original Filings
Healthcare Realty Trust Starboard Value disclosed a new position in the healthcare facilities REIT of 20,903,000 shares. Starboard Value reported that it purchased 16,076,844 shares from Oct. 9 through Nov. 25, 2024, at prices ranging from $15.90 to $18.27.
Following the latest purchases, Starboard Value now owns 5.9% of Healthcare Realty Trust's outstanding stock. Shares of Healthcare Realty Trust have gained some 6.9% year to date.
Decreases in Holdings
Paysafe Cannae Holdings cut its stake in the integrated-payments platform to 2,462,237 shares. Cannae did so through the sale of 917,650 Paysafe shares from Nov. 19 through Nov. 22, 2024, at per share prices ranging from $17.39 to $17.47.
Following the latest sales, Cannae now owns 4.1% of Paysafe's outstanding stock, placing it below the 5% threshold that requires it to report further Paysafe sales. Shares of Paysafe have gained roughly 45.5% during the year.
Getty Images Holdings Neuberger Berman cut its stake in the digital-image marketplace operator to 74,175,262 shares. Neuberger Berman sold 4.1 million Getty shares on Nov. 20, 2024, in an off-market private transaction at a price of $2.46 per share.
Following the latest sales, Neuberger Berman continues to own 18% of Getty Images Holdings' outstanding stock. Shares of Getty Images have lost about 41.4% this year.
GeneDx Holdings OPKO Health reduced its stake in the health-intelligence company to 1,370,841 shares through the sale of 375,833 GeneDx shares from Nov. 11 through Nov. 20, 2024, at prices ranging from $68.20 to $82 apiece. This follows OPKO's prior sales of 425,000 shares from Nov. 4 through Nov. 8 at prices ranging from $74.90 to $80 each, which has been corrected from the 310,000 shares erroneously reported in the prior 13D filing.
Following the latest sales, OPKO continues to own 4.99% of GeneDx's outstanding stock, placing it below the 5% threshold that requires it to report further GeneDx sales. In late October, CEO Katherine Stueland noted that the company achieved profitability in the third quarter.
Email: editors@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 29, 2024 14:43 ET (19:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments